We conducted the novel synthesis of middle molecular weight heparinyl amino acid derivatives (MHADs) to reduce the adverse effect of heparin (HE) based on its anticoagulant activity. Subsequently, we investigated the radical scavenging effects of 12 kinds of MHAD on cultured human umbilical vein endothelial cells (HUV-ECs) damaged by oxygen free radicals using xanthine and xanthine oxidase in vitro . As a result, middle molecular weight heparinyl phenylalanine, middle molecular weight heparinyl leucine, and middle molecular weight heparinyl tyrosine showed significant protective effects on HUV-ECs. In conclusion, these three HE derivatives might be candidates for therapeutic agents to treat diseases attributed to peroxidation.
KeywordsMHADHeparinHUV-ECOxygen Free Radical
Horinouchi, Y., Summers, F.A., Ehrenshaft, M., Kawazoe, K., Tsuchiya, K., Tamaki, T. and Mason, R.P. (2014) Investigating Free Radical Generation in HepG2 Cells Using Immuno-Spin Trapping. Free Radical Biology and Medicine, 75, S33. http://dx.doi.org/10.1016/j.freeradbiomed.2014.10.768
Chaiswing, L., Zhong, W., Cullen, J.J., Oberley, L.W. and Oberley, T.D. (2008) Extracellular Redox State Regulates Features Associated with Prostate Cancer Cell Invasion. Cancer Research, 68, 5820-5826. http://dx.doi.org/10.1158/0008-5472.CAN-08-0162
Naito, R., Nishinakamura, H., Watanabe, T., Nakayama, J. and Kodama, S. (2014) Edaravone, a Free Radical Scavenger, Accelerates Wound Healing in Diabetic Mice. Wounds, 26, 163-171.
Choe, J.Y., Park, K.Y. and Kim, S.K. (2015) Oxidative Stress by Monosodium Urate Crystals Promotes Renal Cell Apoptosis through Mitochondrial Caspase-Dependent Pathway in Human Embryonic Kidney 293 Cells: Mechanism for Urate-Induced Nephropathy. Apoptosis, 20, 38-49. http://dx.doi.org/10.1007/s10495-014-1057-1
Zhao, S., Qian, J., Wang, J., Gong, P., Yang, Z.,Cahoon, J., Wu, X., Duggal, N., Lin, C. and Tang, W. (2015) Effects of Oxygen Concentrations on Postresuscitation Myocardial Oxidative Stress and Myocardial Function in a Rat Model of Cardiopulmonary Resuscitation. Critical Care Medicine, 43, e560-e566. http://dx.doi.org/10.1097/ccm.0000000000001297
Lakshmi, T.S., Shanmugasundaram, N., Shanmuganathan, S., Karthikeyan, K., Meenakshi, J. and Babu, M. (2010) Controlled Release of 2, 3 Desulfated Heparin Exerts Its Anti-Inflammatory Activity by Effectively Inhibiting E-Selectin. Journal of Biomedical Materials Research Part A, 95, 118-128. http://dx.doi.org/10.1002/jbm.a.32791
Qin, Y., Prescott, L.M., Deitch, E.A. and Kaiser, V.L. (2011) Heparin Use in a Rat Hemorrhagic Shock Model Induces Biologic Activity in Mesenteric Lymph Separate from Shock. Shock, 35, 411-421. http://dx.doi.org/10.1097/SHK.0b013e31820239ee
Tyrrell, D.J., Kilfeather, S. and Page, C.P. (1995) Therapeutic Uses of Heparin beyond Its Traditional Role as an Anticoagulant. Trends in Pharmacological Sciences, 16, 198-204. http://dx.doi.org/10.1016/s0165-6147(00)89022-7
Oberkersch, R., Attorresi, A.I. and Calabrese, G.C. (2010) Low-Molecular-Weight Heparin Inhibition in Classical Complement Activation Pathway during Pregnancy. Thrombosis Research, 125, e240-e245. http://dx.doi.org/10.1016/j.thromres.2009.11.030
Karlsson, K. and Marklund, S.L. (1987) Heparin-Induced Release of Extracellular Superoxide Dismutase to Human Blood Plasma. Biochemical Journal, 242, 55-59. http://dx.doi.org/10.1042/bj2420055
Oyanagui, Y. and Sato, S. (1990) Heparin, a Potent Releasing Agent of Extracellular Superoxide Dismutase (EC-SOD C), Supressesischaemic Paw Oedema in Mice. Free Radical Research Communications, 9, 87-99. http://dx.doi.org/10.3109/10715769009148576
Becker, M., Menger, M.D. and Lehr, H.A. (1994) Heparin-Released Superoxide Dismutase Inhibits Postischemic Leukocyte Adhesion to Venular Endothelium. American Journal of Physiology, 267, H925-H930.
Adachi, T., Yamada, H., Futenma, A., Kato, K. and Hirano, K. (1995) Heparin-Induced Release of Extracellular Superoxide Dismutase from (V) to Plasma. The Journal of Biochemistry, 117, 586-590.
Araki, H., Nishikawa, H., Tanaka, S., Nakamura, K., Ohtani, H., Nishimura, S., Shimada, C., Takeda, S., Kawai, K., Kitagawa, C., Kuwahara, M. and Abe, T. (1997) Japan Patent Kokai. 1997-286803.
Hiebert, L.M. and Liu, J.M. (1990) Heparin Protects Cultured Arterial Endothelial Cells from Damage by Toxicoxygen Metabolites. Atherosclerosis, 83, 47-51. http://dx.doi.org/10.1016/0021-9150(90)90129-7
Delaney, C., Wright, R.H., Tang, J.R., Woods, C., Villegas, L., Sherlock, L., Savani, R.C., Abman, S.H. and Nozik, G.E. (2015) Lack of EC-SOD Worsens Alveolar and Vascular Development in a Neonatal Mouse Model of Bleomycin-Induced Bronchopulmonary Dysplasia and Pulmonary Hypertension. Pediatric Research, 31, 166.
Hartney, J.M., Stidham, T., Goldstrohm, D.A., Oberley, D.R.E., Weaver, M.R., Valnickova, H.Z., Scavenius, C., Benninger, R.K., Leahy, K.F., Johnson, R., Gally, F., Kosmider, B., Zimmermann, A.K., Enghild, J.J., Nozik, G.E. and Bowler, R.P. (2014) A Common Polymorphism in Extracellular Superoxide Dismutase Affects Cardiopulmonary Disease Risk by Altering Protein Distribution. Circulation: Cardiovascular Genetics, 7, 659-666. http://dx.doi.org/10.1161/CIRCGENETICS.113.000504
Perveen, S., Patel, H., Arif, A., Younis, S., Codipilly, C.N. and Ahmed, M. (2012) Role of EC-SOD Overexpression in Preserving Pulmonary Angiogenesis Inhibited by Oxidative Stress. PLoS One, 7, e51945. http://dx.doi.org/10.1371/journal.pone.0051945
Manni, M.L., Tomai, L.P., Norris, C.A., Thomas, L.M., Kelley, E.E., Salter, R.D., Crapo, J.D., Chang, L.Y., Watkins, S.C., Piganelli, J.D. and Oury, T.D.(2011) Extracellular Superoxide Dismutase in Macrophages Augments Bacterial Killing by Promoting Phagocytosis. American Journal of Pathology, 178, 2752-2759. http://dx.doi.org/10.1016/j.ajpath.2011.02.007
Oda, T., Akaike, T., Hamamoto, T., Suzuki, F., Hirano, T. and Maeda, H. (1989) Oxygen Radicals in Influenza-Induced Pathogenesis and Treatment with Pyran-Polymer Conjugated SOD. Science, 244, 974-975. http://dx.doi.org/10.1126/science.2543070
Serena, C., Calvo, E., Clares, M.P., Diaz, M.L., Chicote, J.U., Beltrán, D.R., Fontova, R. and Rodriguez, A. (2015) Significant in Vivo Anti-Inflammatory Activity of Pytren4Q-Mn a Superoxide Dismutase 2 (SOD2) Mimeticscorpiand-Like Mn (II) Complex. PLoS One, 10, e0119102. http://dx.doi.org/10.1371/journal.pone.0119102
Tamai, M., Furuta, H., Kawashima, H., Doi, A., Hamanishi, T., Shimomura, H., Sakagashira, S., Nishi, M., Sasaki, H., Sanke, T. and Nanjo, K. (2006) Extracellular Super-Oxide Dismutase Gene Polymorphism Is Associated with Insulin Resistance and the Susceptibility to Type 2 Diabetes. Diabetes Research and Clinical Practice, 71, 140-145. http://dx.doi.org/10.1016/j.diabres.2005.05.006
Kwon, M.J., Kim, B., Lee, Y.S. and Kim, T.Y. (2012) Role of Superoxide Dismutase 3 in Skin Inflammation. Journal of Dermatological Science, 67, 81-87. http://dx.doi.org/10.1016/j.jdermsci.2012.06.003
Markland, S.L., Holme, E. and Hellner, L. (1982) Superoxide Dismutase in Extracellular Fluids. Clinica Chimica Acta, 126, 41-51. http://dx.doi.org/10.1016/0009-8981(82)90360-6
Nozik, G.E., Suliman, H.B. and Piantadosi, C.A. (2005) Extracellular Superoxide Dismutase. The International Journal of Biochemistry & Cell Biology, 37, 2466-2471. http://dx.doi.org/10.1016/j.biocel.2005.06.012
Hiebert, L.M. and Liu, J.M. (1991) Protective Action of Polyelectrolytes on Endothelium. Seminars in Thrombosis and Hemostasis, 17, 42-46.
Barrowcliffe, T.W., Mulloy, B., Johnson, E.A. and Thomas, D.P. (1989) The Anticoagulant Activity of Heparin: Measurement and Relationship to Chemical Structure. Journal of Pharmaceutical and Biomedical Analysis, 7, 217-226. http://dx.doi.org/10.1016/0731-7085(89)80086-X
Salla, E., Dimakakos, E.P., Tsagkouli, S., Giozos, I., Charpidou, A., Kainis, E. and Syrigos, K.N. (2015) Venous Thromboembolism in Patients Diagnosed with Lung Cancer. Angiology, in press.
Ezzatzadegan, J.S., Mahmoodi, M.S., Behroozi, F., Roozbeh, J. and Emamghoreishi, F. (2014) Effect of Switching Unfractionated Heparin to Low-Molecular-Weight Heparin on Serum Potassium in Hemodialysis Patients. Iranian Journal of Kidney Diseases, 8, 475-480.
Chuang, F.R., Chen, T.C., Lee, C.H., Ng, H.Y., Wang, I.K., Chang, H.W., Chuang, P.H., Wu, C.H., Yang, C.C. and Su, Y.J. (2011) Clinical Safety and Anticoagulation Efficacy of Low-Molecular-Weight Heparins in Chronic Hemodialysis Patients: A Single Medical Center Experience. Renal Failure, 33, 990-997. http://dx.doi.org/10.3109/0886022X.2011.618905